| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/23/2007 | EP1786422A2 Aryl urea derivatives for treating obesity |
| 05/23/2007 | EP1786415A1 Metabolism-modulating agents and uses therefor |
| 05/23/2007 | EP1786414A2 Novel statin pharmaceutical compositions and related methods of treatment |
| 05/23/2007 | EP1385548B1 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 05/23/2007 | EP1181014B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 05/23/2007 | EP1019074B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 05/23/2007 | EP0859777B1 8-azabicyclo(3.2.1)oct-2-ene derivatives, their preparation and use |
| 05/23/2007 | EP0820469B1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 05/23/2007 | CN1968949A Proline derivatives and their use as dipeptidyl peptidase IV inhibitors |
| 05/23/2007 | CN1968928A Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 05/23/2007 | CN1968921A Glucagon receptor antagonists, preparation and therapeutic uses |
| 05/23/2007 | CN1968692A Compositions for affecting weight loss |
| 05/23/2007 | CN1968691A Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 05/23/2007 | CN1968680A Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin |
| 05/23/2007 | CN1966500A Quinoxaline derivative, preparation method and uses |
| 05/23/2007 | CN1966484A New phenoxy eicosanoic acid derivative and its medical use |
| 05/23/2007 | CN1966024A Pharmaceutical composition for treating diabetes complication and preparation process thereof |
| 05/23/2007 | CN1965994A Method for preparing oral liquid for sportsman |
| 05/23/2007 | CN1965982A Chinese medicine for lowering blood fat and protecting liver and method for preparing same |
| 05/23/2007 | CN1965970A Medicament for treating cardiovascular and cerebrovascular diseases |
| 05/23/2007 | CN1965954A Tablet having kudzuvine root and astragalus root and method for preparing same |
| 05/23/2007 | CN1965936A Prescription of qi and blood harmonizing liquid and preparation process thereof |
| 05/23/2007 | CN1965929A Preparation method of medicament for treating diabetes |
| 05/23/2007 | CN1965926A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| 05/23/2007 | CN1965924A Medicament for lowering blood fat and dilating coronary artery |
| 05/23/2007 | CN1965915A Method for extracting bitter buckwheat flavone in high purity |
| 05/23/2007 | CN1965885A Application of total flavones of chickpea in preparation of medicament for treating diabetes |
| 05/23/2007 | CN1965873A Chinese medicinal extract having blood sugar-lowering activity, its preparation process, composition and use |
| 05/23/2007 | CN1965863A Method for preparing compound amino acid oral liquid by using animals placenta |
| 05/23/2007 | CN1965862A Orally administered compound antihyperlipidemic |
| 05/23/2007 | CN1965859A Sodium selenite solution containing clustered water used for animal |
| 05/23/2007 | CN1965843A Use of statin and aspirin in preparation of medicine for treating blood high viscosity syndrome |
| 05/23/2007 | CN1965817A Sustained release tablet of glibenclamide and preparation process thereof |
| 05/23/2007 | CN1965813A Compound soft capsule of propolis |
| 05/23/2007 | CN1965811A Sustained release tablet of calcium dobesilate and preparation process thereof |
| 05/23/2007 | CN1965807A Fat emulsion injection prepared by using saturated fatty acid lecithin |
| 05/23/2007 | CN1965806A Fat emulsion injection liquid containing soybean oil, medium chain triglyceride, olive oil and fish oil and method for preparing the same |
| 05/23/2007 | CN1965805A Submicron emulsion injection liquid of CoQ10 and preparation process thereof |
| 05/23/2007 | CN1965696A Health tea capable of lowering blood sugar |
| 05/23/2007 | CN1317385C Cheese lactobacillus Bd-II strain and use for decreasing blood fat |
| 05/23/2007 | CN1317301C Modulation of IL-2-and IL-15-mediated T cell responses |
| 05/23/2007 | CN1317298C Extraction method and uses of traditional Chinese medicine cassia seed protein |
| 05/23/2007 | CN1317278C Heterocyclic compounds and their use as medicines |
| 05/23/2007 | CN1317272C Process for extracting folium mori flavone |
| 05/23/2007 | CN1317014C Soaking bath Chinese medicine for treating diabetes |
| 05/23/2007 | CN1317010C Dripping pill for tonifying heart and kidney and its preparing method |
| 05/23/2007 | CN1317009C Medicine for treating diabetes and its producing method |
| 05/23/2007 | CN1317005C Dragon's blood extract with alpha-glycosidase inhibiting activity and its prepn making process and use |
| 05/23/2007 | CN1316966C Otacosane alcohol extract micro-encapsulation powder and preparation method thereof |
| 05/22/2007 | US7220897 Δ4-desaturase genes and uses thereof |
| 05/22/2007 | US7220880 For therapy of diabetes mellitus, cardiovascular disease, obesity, Syndrome X and gastrointestinal disease, such as, inflammatory bowel disease |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220856 Substituted quinoline CCR5 receptor antagonists |
| 05/22/2007 | US7220779 Using 5-aminolevulinic acid |
| 05/22/2007 | US7220777 Lactam derivatives as antagonists for human 11cby receptors |
| 05/22/2007 | US7220773 Heterocylic amines used as antidiabetic or hyperglycemic agents |
| 05/22/2007 | US7220771 Jun n-terminal kinase inhibitors |
| 05/22/2007 | US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 05/22/2007 | US7220765 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 05/22/2007 | US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example |
| 05/22/2007 | US7220735 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion |
| 05/22/2007 | US7220722 Lipoprotein-regulating medicants |
| 05/22/2007 | CA2382573C Substituted benzylthiazolidine-2,4-dione derivatives |
| 05/22/2007 | CA2368347C Glucokinase activators |
| 05/22/2007 | CA2241466C Pharmaceutical composition containing angiotensin ii antagonist |
| 05/22/2007 | CA2206012C Novel compounds for the treatment and prevention of diabetes |
| 05/18/2007 | WO2007056546A1 Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor |
| 05/18/2007 | WO2007056497A1 Compounds and compositions as ppar modulators |
| 05/18/2007 | WO2007056496A1 Oxazole and thiazole ppar modulator |
| 05/18/2007 | WO2007056280A1 Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitors |
| 05/18/2007 | WO2007056279A2 Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors |
| 05/18/2007 | WO2007056275A2 Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors |
| 05/18/2007 | WO2007056184A2 Azaindole compounds and use thereof as phospholipase-a2 inhibitors |
| 05/18/2007 | WO2007055743A2 Treatment of obesity and related disorders |
| 05/18/2007 | WO2007055728A1 Treatment of obesity and related disorders |
| 05/18/2007 | WO2007055418A1 Aza-substituted spiro derivative |
| 05/18/2007 | WO2007055327A1 Jelly composition |
| 05/18/2007 | WO2007055093A1 Tricyclic compound |
| 05/18/2007 | WO2007054580A1 N-sulfamoyl-n’-benzopyranpiperidines as inhbitors of carbonic anhydrases |
| 05/18/2007 | WO2007054577A1 Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase iv inhibitors |
| 05/18/2007 | WO2007054451A1 Use of combinations of nitric oxide-releasing aspirin and aspirin for the treatment of cardiovascular diseases |
| 05/18/2007 | WO2007054269A2 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts |
| 05/18/2007 | WO2007054197A1 Food products, ingredients therefor and use of those food products and ingredients |
| 05/18/2007 | WO2007053946A1 Method of treating diabetes and/or obesity with reduced nausea side effects using an insulinotropic peptide conjugated to albumin |
| 05/18/2007 | WO2007034012A3 Method of obtaining amorphous calcium atorvastatin |
| 05/18/2007 | WO2007029086A3 Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-iv inhibitors |
| 05/18/2007 | WO2007028083A3 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 05/18/2007 | WO2007017695A3 Dihydroxyanthraquinones and their use |
| 05/18/2007 | WO2007008937A3 Adiponectin variants |
| 05/18/2007 | WO2006112703A3 Induction of omega-oxidation of fatty acids by cytochrome p450 for counteracting fatty acid accumulation |
| 05/18/2007 | WO2006106438A3 Modulators of ppar activity |
| 05/18/2007 | CA2629864A1 N-sulfamoyl-n'-benzopyranpiperidines as inhbitors of carbonic anhydrases |
| 05/18/2007 | CA2629018A1 Aza-substituted spiro derivative |
| 05/18/2007 | CA2628881A1 Diaryl urea for treating diabetic neuropathy |
| 05/18/2007 | CA2628305A1 Jelly composition |
| 05/18/2007 | CA2628051A1 Treatment of obesity and related disorders |
| 05/18/2007 | CA2627353A1 Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitors |
| 05/18/2007 | CA2627352A1 Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors |
| 05/18/2007 | CA2627349A1 Azaindole compounds and use thereof as phospholipase-a2 inhibitors |
| 05/18/2007 | CA2627043A1 Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors |